1. Home
  2. Stocks
  3. Jbchepharm Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • J B Chemicals & Pharmaceuticals Share Price J B Chemicals & Pharmaceuticals

    Large Cap
    ₹1,779.6
    -18.2 (-1.01%)
    20 April, 2024 20:54 BSE: 506943 NSE: JBCHEPHARMISIN: INE572A01036
    Split

    Start SIP in J B Chemicals & Pharmaceuticals

    Start SIP

    J B Chemicals & Pharmaceuticals Performance

    Day Range

    • Low 1,770
    • High 1,798
    ₹ 1,779

    52 Week Range

    • Low 875
    • High 1,940
    ₹ 1,779
    • Open Price1,795
    • Previous Close1,798
    • Volume202911

    J B Chemicals & Pharmaceuticals Share Price

    • Over 1 Month +12.28%
    • Over 3 Month +10.05%
    • Over 6 Month +32.99%
    • Over 1 Year +67.18%

    J B Chemicals & Pharmaceuticals Key Statistics

    P/E Ratio 53.7
    PEG Ratio 2
    Market Cap Cr 27,619
    Price to Book Ratio 11.1
    EPS 24.9
    Dividend 0.6
    Relative Strength Index 68.07
    Money Flow Index 70.79
    MACD Signal 36.54
    Average True Range 44.86
    J B Chemicals & Pharmaceuticals Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 800837853699
    Operating Expenses Qtr Cr 585602618538
    Operating Profit Qtr Cr 215235235161
    Depreciation Qtr Cr 33323131
    Interest Qtr Cr 1291112
    Tax Qtr Cr 48565433
    Net Profit Qtr Cr 12814514589
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 2,893
    Operating Expenses Annual Cr 2,219
    Operating Profit Annual in Cr 665
    Depreciation Cr 112
    Interest Annual Cr 34
    Tax Annual Cr 138
    Net Profit Annual Cr 389
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 629
    Cash from Investing Activity Annual Cr -956
    Cash from Financing Annual Activity Cr 343
    Net Cash Flow Annual Cr 16
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 2,442
    Fixed Assets Annual Cr 1,877
    Total Non Current Assets Annual Cr 2,072
    Total Current Assets Annual Cr 1,398
    Total Assets Annual Cr 3,470
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 316
    ROE Annual % 16
    ROCE Annual % 19
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 23
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 845882896762
    Operating Expenses Qtr Cr 621638664599
    Operating Profit Qtr Cr 223244232164
    Depreciation Qtr Cr 34323132
    Interest Qtr Cr 12101214
    Tax Qtr Cr 50585235
    Net Profit Qtr Cr 13415114288
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 3,159
    Operating Expenses Annual Cr 2,454
    Operating Profit Annual in Cr 696
    Depreciation Cr 114
    Interest Annual Cr 36
    Tax Annual Cr 145
    Net Profit Annual Cr 410
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 626
    Cash from Investing Activity Annual Cr -962
    Cash from Financing Annual Activity Cr 357
    Net Cash Flow Annual Cr 20
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 2,480
    Fixed Assets Annual Cr 1,899
    Total Non Current Assets Annual Cr 2,026
    Total Current Assets Annual Cr 1,528
    Total Assets Annual Cr 3,554
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 321
    ROE Annual % 17
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 22
    Sign Up to Know More
    Invest in J B Chemicals & Pharmaceuticals

    J B Chemicals & Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹1,779.6
    -18.2 (-1.01%)
    pointer
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹1,716.70
    • 50 Day
    • ₹1,665.96
    • 100 Day
    • ₹1,609.10
    • 200 Day
    • ₹1,491.76
    • 20 Day
    • ₹1,698.54
    • 50 Day
    • ₹1,657.24
    • 100 Day
    • ₹1,616.39
    • 200 Day
    • ₹1,493.18

    J B Chemicals & Pharmaceuticals Resistance and Support

    PIVOT
    ₹1,782.65
    Resistance
    First Resistance 1,794.95
    Second Resistance 1,810.30
    Third Resistance 1,822.60
    RSI 68.07
    MFI 70.79
    MACD Single Line 36.54
    MACD 47.29
    Support
    First Resistance 1,767.30
    Second Resistance 1,755.00
    Third Resistance 1,739.65

    J B Chemicals & Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 205,388 17,277,239 84.12
    Week 266,943 19,606,982 73.45
    1 Month 199,383 14,923,780 74.85
    6 Month 191,399 11,066,699 57.82

    J B Chemicals & Pharmaceuticals Result Highlights

    J B Chemicals & Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    J B Chemicals & Phar is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2884.16 Cr. and Equity Capital is Rs. 15.48 Cr. for the Year ended 31/03/2023. J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380.
    Market Cap 27,671
    Sales 3,189
    Shares in Float 7.13
    No of funds 230
    Yield 1
    Book Value 11.3
    U/D Vol ratio 2
    LTDebt / Equity 16
    Alpha 0.24
    Beta 0.66

    J B Chemicals & Pharmaceuticals

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 53.78%53.83%53.86%53.91%
    Mutual Funds 15.45%15.66%15.57%15.57%
    Insurance Companies 2.36%2.3%2.45%2.55%
    Foreign Portfolio Investors 11.06%10.35%10.05%9.53%
    Financial Institutions/ Banks
    Individual Investors 14.69%15.16%15.33%15.66%
    Others 2.66%2.7%2.74%2.78%

    J B Chemicals & Pharmaceuticals Management

    Name Designation
    Mr. Ranjit Shahani Chairman & Ind.Director
    Mr. Nikhil Chopra WholeTime Director & CEO
    Mr. Prashant Kumar Non Executive Director
    Mr. Gaurav Trehan Non Executive Director
    Mr. Sumit Bose Independent Director
    Ms. Padmini Khare Kaicker Independent Director

    J B Chemicals & Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    J B Chemicals & Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-02-06 Quarterly Results & Interim Dividend
    2023-11-07 Quarterly Results
    2023-08-09 Quarterly Results
    2023-05-24 Audited Results, Dividend & Stock Split
    2023-02-08 Quarterly Results & Interim Dividend
    Date Purpose Remarks
    2024-02-16 INTERIM Rs.5.50 per share(550%)Interim Dividend
    2023-02-18 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2022-02-24 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2021-02-22 INTERIM Rs.8.50 per share(425%)Interim Dividend
    Date Purpose Remarks
    2023-09-18 Split Rs.0.00 split from Rs. 2/- to 1/-.

    J B Chemicals & Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 45,749
    Kotak Emerging Equity Scheme Growth 39,685
    Nippon India Multi Cap Fund - Growth 27,746
    Axis Midcap Fund Growth 25,537
    Nippon India Growth Fund - Growth 24,796

    J B Chemicals & Pharmaceuticals FAQs

    What is Share Price of J B Chemicals & Pharmaceuticals ?

    J B Chemicals & Pharmaceuticals share price is ₹1,779 As on 20 April, 2024 | 20:40

    What is the Market Cap of J B Chemicals & Pharmaceuticals ?

    The Market Cap of J B Chemicals & Pharmaceuticals is ₹27618.5 Cr As on 20 April, 2024 | 20:40

    What is the P/E ratio of J B Chemicals & Pharmaceuticals ?

    The P/E ratio of J B Chemicals & Pharmaceuticals is 53.7 As on 20 April, 2024 | 20:40

    What is the PB ratio of J B Chemicals & Pharmaceuticals ?

    The PB ratio of J B Chemicals & Pharmaceuticals is 11.1 As on 20 April, 2024 | 20:40

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.